Comparison of the effects of E coli STa with E coli LT, Clostridium difficile toxin A and osmotic burdens on small intestinal fluid transport: additional proof that STa is not a secretory enterotoxin

Using a recirculation procedure to perfuse anaesthetised rat jejunum, E. coli STa enterotoxin can be shown to inhibit net fluid absorption profoundly, while not causing net fluid secretion, provided fluid measurement is by mass or volume. This observation contradicts many reports of STa causing secretion, implying that the recovered volume technique in the anaesthetised animal over a period of some hours cannot detect secretion because of conjectured or unspecified flaws. Experiments are presented here confirming the viability of the perfusion protocol used in this laboratory but also demonstrate that if secretion were to be occurring, the recovered volume protocol would detect it. It will only return a negative finding, if secretion does not occur. To this end, the effect of two secretory toxins on intestinal fluid movement in a closed loop preparation were studied to demonstrate that the anaesthetic, intestinal preparation or perfusion duration did not hinder the demonstration of net secretion when the intestine was exposed to E. coli LT and C. difficile toxin A.. It is evident that STa itself only reduces net absorption but can appear to be secretory if driving forces such as luminal osmotic pressure or capillary hydrostatic pressure through vasodilatation are introduced, as was likely to have occurred with pithing and theophylline. The recognition that STa is a non-secretory enterotoxin necessarily falsifies several alternative methods that claim to demonstrate secretion. Since STa is not secretory many other substances identified by these methods need also not be secretory and alternative explanations must be found to explain their action. The importance of recognising that action on the small intestine cannot be attributed to a secretory mechanism within the enterocyte adds further weight to the concept that where net secretion does occur, the likely mechanism for it is a combination of increased vasodilatation together with increased hydraulic conductivity

Assessing the genetic and pathogenic variability of Pyrenophora teres f. maculata (spot form net blotch of barley) and its ability to overcome currently-used sources of resistance on the Canadian prairies

Non-Peer ReviewedEighty two isolates of the fungus Pyrenophora teres f. maculata, causal agent of spot form net blotch (SFNB) of barley, were collected across the Canadian prairies. Following genetic analysis using 13 microsatellite DNA markers, 27 isolates were selected to assess the degree of pathogenic variation in the fungus. Pathogenic variability was evaluated by inoculating isolates onto 11 barley genotypes as differential hosts at the seedling stage. One week following inoculation, the second and third leaves of each plant were rated on to a 1–9 disease severity scale, and plants with scores of 1–3 and >3 were scored as resistant and susceptible, respectively. The entire experiment was repeated. Cluster analysis revealed 13 distinct pathotype groups (virulence patterns) among the 27 representative isolates. Disease severity ratings ranged from 2.2 to 6.1 with a mean of 4.6. To assess the risk of resistance breakdown, the resistance of four barley cultivars (‘AAC Synergy’, ‘CDC Meredith’, ‘Cerveza’ and ‘Major’), which had been previously identified as resistant to SFNB on the Canadian prairies, was evaluated at the seedling stage against six isolates of P. teres f. maculata representing four different pathotypes. The resistance in ‘CDC Meredith’ was clearly overcome by all isolates tested, while ‘AAC Synergy’, ‘Cerveza’ and ‘Major’ still exhibited resistance against all of the pathotypes. The identification of fungal isolates virulent on ‘CDC Meredith’ suggests that producers should avoid growing the same resistant barley variety in short rotation, and avoid relying on resistance as the sole approach to disease management. Judicious use of fungicides, coupled with rotations of at least two years between barley crops and diversity in the barley varieties grown, will promote effective and sustainable management of spot form net blotch

Relaxation equations for two-dimensional turbulent flows with a prior vorticity distribution

Using a Maximum Entropy Production Principle (MEPP), we derive a new type of relaxation equations for two-dimensional turbulent flows in the case where a prior vorticity distribution is prescribed instead of the Casimir constraints [Ellis, Haven, Turkington, Nonlin., 15, 239 (2002)]. The particular case of a Gaussian prior is specifically treated in connection to minimum enstrophy states and Fofonoff flows. These relaxation equations are compared with other relaxation equations proposed by Robert and Sommeria [Phys. Rev. Lett. 69, 2776 (1992)] and Chavanis [Physica D, 237, 1998 (2008)]. They can provide a small-scale parametrization of 2D turbulence or serve as numerical algorithms to compute maximum entropy states with appropriate constraints. We perform numerical simulations of these relaxation equations in order to illustrate geometry induced phase transitions in geophysical flows.Comment: 21 pages, 9 figure

The effect of transmucosal 0.2mg/kg Midazolam premedication on dental anxiety, anaesthetic induction and psychological morbidity in children undergoing general anaesthesia for tooth extraction

<b>Background:</b> The project aims were to evaluate the benefit of transmucosal Midazolam 0.2mg/kg pre-medication on anxiety, induction behaviour and psychological morbidity in children undergoing general anaesthesia (GA) extractions. <b>Method:</b> 179 children aged 5-10 years (mean 6.53 years) participated in this randomised, double blind, placebo controlled trial. Ninety children had Midazolam placed in the buccal pouch. Dental anxiety was recorded pre operatively and 48 hours later using a child reported MCDAS-FIS scale. Behaviour at anaesthetic induction was recorded and psychological morbidity was scored by the parent using the Rutter Scale pre-operatively and again one-week later. Subsequent dental attendance was recorded at one, three and six months after GA. <b>Results:</b> Whilst levels of mental anxiety did not reduce overall, the most anxious patients demonstrated a reduction in anxiety after receiving midazolam premedicationmay (p=0.01). Neither induction behaviour nor psychological morbidity improved. Irrespective of group, parents reported less hyperactive (p= 0.002) and more prosocial behaviour (p=0.002) after the procedure:;, older children improved most (p=0.048), Post GA Dental attendance was poor and unrelated to after the procedure and unaffected by premedication. <b>Conclusion:</b> 0.2mg/kg buccal Midazolam provided some evidence for reducing anxiety in the most dentally anxious patients. However, induction behaviour, psychological morbidity and subsequent dental attendance were not found to alter between the premedication groups